🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Wuhan Healthgen Biotechnology Corp. (SHA:688765)
China flag China · Delayed Price · Currency is CNY
25.67
-1.60 (-5.87%)
At close: Nov 20, 2026

SHA:688765 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
53.0347.2124.0623.4712.8224.84
Other Revenue
0.40.651.150.790.580.68
53.4347.8625.2224.2613.425.52
Revenue Growth
88.16%89.81%3.92%81.08%-47.49%18.33%
Cost of Revenue
36.5931.5310.6812.26.189.9
Gross Profit
16.8316.3314.5312.067.2215.62
Selling, General & Admin
73.5762.8349.3958.8458.9971.31
Research & Development
89.1192.66116.79159.1110.575.21
Other Operating Expenses
11.272.89-17.391.770.770.28
Operating Expenses
173.64158.39148.78219.72170.26146.8
Operating Income
-156.81-142.06-134.24-207.66-163.04-131.18
Interest Expense
-5.56-7.56-5.1-0.66-0.23-0.53
Interest & Investment Income
10.233.012.45.7914.642.73
Currency Exchange Gain (Loss)
0.440.05-0.14-0.130.39-0.06
Other Non Operating Income (Expenses)
-0.12-0.14-0.05-0.020-0.09
EBT Excluding Unusual Items
-151.82-146.7-137.12-202.68-148.24-129.13
Gain (Loss) on Sale of Assets
2.643.79-1.281.010.33-11.27
Asset Writedown
----0-0
Legal Settlements
-25.61-31.24-12.97--1.49-
Other Unusual Items
36.6317.12-14.715.826.36
Pretax Income
-138.17-157.04-151.37-186.96-143.58-134.04
Net Income
-138.17-157.04-151.37-186.96-143.58-134.04
Net Income to Common
-138.17-157.04-151.37-186.96-143.58-134.04
Net Income Growth
------
Shares Outstanding (Basic)
328283268267261216
Shares Outstanding (Diluted)
328283268267261216
Shares Change
22.93%5.56%0.36%2.31%20.75%333.57%
EPS (Basic)
-0.42-0.56-0.56-0.70-0.55-0.62
EPS (Diluted)
-0.42-0.56-0.56-0.70-0.55-0.62
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-770.36-666.38-220.38-224.45-424.7-263.44
Free Cash Flow Per Share
-2.35-2.35-0.82-0.84-1.63-1.22
Gross Margin
31.50%34.12%57.64%49.71%53.89%61.21%
Operating Margin
-293.51%-296.82%-532.36%-855.82%-1216.74%-514.08%
Profit Margin
-258.62%-328.11%-600.28%-770.53%-1071.49%-525.26%
Free Cash Flow Margin
-1441.94%-1392.31%-873.96%-925.01%-3169.45%-1032.38%
EBITDA
-95.36-80.19-74.7-160.56-150.66-121.52
EBITDA Margin
-178.49%-167.54%-296.25%---
D&A For EBITDA
61.4561.8859.5447.112.389.67
EBIT
-156.81-142.06-134.24-207.66-163.04-131.18
EBIT Margin
-293.51%-296.82%----
Revenue as Reported
53.4347.8625.22---
Advertising Expenses
-0.570.30.120.070.13